首页> 外文学位 >Surfaces modulate beta-amyloid peptide aggregation associated with Alzheimer's disease.
【24h】

Surfaces modulate beta-amyloid peptide aggregation associated with Alzheimer's disease.

机译:表面调节与阿尔茨海默氏病有关的β-淀粉样肽聚集。

获取原文
获取原文并翻译 | 示例

摘要

A hallmark of Alzheimer's disease, a late onset neurodegenerative disease, is the presence of neuritic amyloid plaques deposited within the brain composed of β-amyloid (Aβ) peptide aggregates. Aβ can aggregate into a variety of polymorphic aggregate structures under different chemical environments, specifically affected by the presence of differing surfaces. There are several point mutations clustered around the central hydrophobic core of Aβ (E22G Arctic mutation, E22K Italian mutation, D23N Iowa mutation, and A21G Flemish mutation). These mutations are associated with hereditary diseases ranging from almost pure cerebral amyloid angiopathy to typical Alzheimer’s disease pathology with both plaques and tangles. To determine how these different point mutations, which modify both peptide charge and hydrophobic character, altered Aβ aggregation and morphology under free solution conditions, at an anionic surface/liquid interface and in the presence of supported lipid bilayers, atomic force microscopy was used. Additionally, the non-native conformation of Aβ leads to the formation of nanoscale, toxic aggregates which have been shown to strongly interact with supported lipid bilayers, which may represent a key step in potential toxic mechanisms. Understanding how specific regions of Aβ regulate its aggregation in the absence and presence of surfaces can provide insight into the fundamental interaction of Aβ with cellular surfaces. Specific fragments of Aβ (Aβ1-11, Aβ 1-28, Aβ10-26, Aβ12-24, Aβ 16-22, Aβ22-35, and Aβ1-40), represent a variety of chemically unique regions along Aβ, i.e., the extracellular domain, the central hydrophobic core, and transmembrane domain. Using various scanning probe microscopic techniques, the interaction of these Aβ sequences with lipid membranes was shown to alter aggregate morphology and induce mechanical changes of lipid bilayers compared to aggregates formed under free solution conditions. Lastly, in order to determine how chemical environment can lead to distinct polymorph fibril formation influencing disease pathology, various peptide preparation and fibril growth conditions of Aβ were studied in free solution and with a model lipid membrane.
机译:阿尔茨海默氏病(一种迟发性神经退行性疾病)的标志是沉积在脑内的由β-淀粉样蛋白(Aβ)肽聚集物组成的神经淀粉样斑块的存在。在不同的化学环境下,Aβ可以聚集成各种多态的聚集体结构,特别是受不同表面的存在的影响。在Aβ的中央疏水核心周围聚集了几个点突变(E22G北极突变,E22K意大利突变,D23N爱荷华州突变和A21G佛兰德突变)。这些突变与遗传疾病有关,从几乎纯的脑淀粉样血管病到典型的患有斑块和缠结的阿尔茨海默氏病病理。为了确定这些改变肽电荷和疏水特性的不同点突变如何在游离溶液条件下,在阴离子表面/液体界面以及在支持的脂质双层存在下改变Aβ聚集和形态,使用了原子力显微镜。另外,Aβ的非天然构象导致形成纳米级的有毒聚集体,该聚集体已显示出与支持的脂质双层强烈相互作用,这可能代表了潜在毒性机制中的关键步骤。了解Aβ的特定区域如何在不存在和存在表面的情况下调节其聚集,可以深入了解Aβ与细胞表面的基本相互作用。 Aβ的特定片段(Aβ1-11,Aβ1-28,Aβ10-26,Aβ12-24,Aβ16-22,Aβ22-35和Aβ1-40)代表沿Aβ的各种化学独特区域,即细胞外结构域,中央疏水核心和跨膜结构域。与在自由溶液条件下形成的聚集体相比,使用各种扫描探针显微镜技术显示,这些Aβ序列与脂质膜的相互作用可改变聚集体形态并诱导脂质双层的机械变化。最后,为了确定化学环境如何导致影响疾病病理的独特多晶型原纤维形成,在游离溶液中和模型脂质膜上研究了Aβ的各种肽制备和原纤维生长条件。

著录项

  • 作者

    Yates, Elizabeth Anne.;

  • 作者单位

    West Virginia University.;

  • 授予单位 West Virginia University.;
  • 学科 Biology Neuroscience.;Biophysics General.;Nanoscience.;Chemistry Biochemistry.
  • 学位 Ph.D.
  • 年度 2013
  • 页码 225 p.
  • 总页数 225
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号